Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma

Summary

This is a single arm, prospective trial to evaluate the efficacy and safety of Chidamide in combination with previous chemotherapy in peripheral T cell lymphoma patients who did not achieve complete response after 3 cycles of chemotherapy in interim evaluation.

Timeline

Start

2015-11

Primary completion

2018-11

Completion

2019-11

Drugs

Indications